About Prevtec Microbia

Prevtec Microbia is a Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in food animals. In a world where antibiotic use in animal production is increasingly controlled, we develop innovative alternatives to antibiotics. Our products represent sustainable solutions. Prevtec Microbia is an innovation-centric company that operates in many areas of the world through strategic alliances, particularly in Canada and Europe. Prevtec Microbia is proud to be part of the quest for better ways to feed the world.
$33 billion

Estimated value of the global animal health industry by 2020*

* Vetnosis

33

Number of countries where Coliprotec® F4 is approved for use

10+

We have been devising innovative solutions to challenges in livestock production for over a decade.

News
Prevtec Microbia Receives Positive Final Opinion from European Medicines Agency for Coliprotec® F4/F18 for pigs
15/11/2016
regulatory

First oral bivalent live vaccine for immunization of pigs against F4 and F18 Escherichia coli post-weaning diarrhea. Prevtec Microbia Inc. is pleased to announce that its German subsidiary, Prevtec Microbia GmbH, received a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA), recommending the granting of a marketing authorization for Coliprotec® F4/F18 in the European Union.…

+
The Coliprotec® F4 among the 15 most important inventions of Quebec
25/10/2016
media

Dr. John Fairbrother and Dr. Eric Nadeau were honored to be mentioned in the book Cracking the Quebec Code, by Jean-Marc Léger, published by Juniper. This book highlights the seven character traits that make Quebecers unique, creativity is recognized as a main quality. Creativity results in numerous inventions such as the Coliprotec® F4 vaccine, developed by Dr. Fairbrother and Dr. Nadeau, which is today at…

+
  •  

    Antimicrobial resistance (AMR) is resistance of a microorganism to an antimicrobial medicine to which it was originally sensitive. AMR occurs naturally but the phenomenon is hugely increased by excessive and inappropriate use of antimicrobial medicines and poor infection control practices in animals and humans.

     

     

    Source: European Commission, http://europa.eu/rapid/press-release_STATEMENT-15-6097_en.htm